Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **UDP glucuronosyltransferase 2 family, polypeptide B11 pseudogene** (ENSG00000248763) is a **pseudogene** related to the UGT2B11 gene. Unlike active members of the UGT (UDP-glucuronosyltransferase) family, which encode enzymes catalyzing glucuronidation—a critical process in detoxification and metabolism of endogenous and exogenous compounds—this pseudogene does not produce a functional protein and has no known biological activity or disease association. It is not considered a drug target or therapeutic receptor[5][1]. **Context and explanation:** - The "pseudogene" status means that this genomic locus does not encode a protein product, nor does it have recognized enzymatic function or therapeutic relevance[5][1]. - The active UGT2B11 enzyme (in contrast) would be classified as an "enzyme" and play a role in xenobiotic and hormone metabolism, but this is not applicable to this specific pseudogene[10][7][8]. - There is nothing to suggest ENSG00000248763 (as a pseudogene) is used for drug targeting, biomarker assays, or associated with disease; these features are associated with functional UGT enzymes—not their pseudogenes. **Summary for structured data extraction:** - This entry is a non-functional pseudogene, not a therapeutic or biological target, and is likely an incorrect or non-actionable target for drug discovery or clinical translation[5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP glucuronosyltransferase 2 family, polypeptide B11 pseudogene.